NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120

Journal of Biochemical and Biophysical Methods

Volumn 34, Issue 2, 1997, Pages 83-98

  Sarma, A V S ^a   Raju, T V ^a   Kunwar, A C ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

turn; gp120; HIV; Nascent helix; Nuclear magnetic resonance; Peptides; Principal neutralizing determinant

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRUS ENVELOPE;

HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE MAPPING; PEPTIDES; PROTEIN CONFORMATION;

EID: 0030913036     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(97)01205-0     Document Type: Article

References (36)

1. Rusche, J.R., Javaherian, K., McDanal, C., Petro, J., Lynn, D.L., Grimaila, R., Langlois, A., Gall, R.C., Arthur, L.O., Fischinger, P.J., Bolognesi, D.P., Putney, S.D. and Matthews, T.J., Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp 120, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 3198-3202.
2. Palker, T.J., Clark, M.E., Langlois, A.J., Matthews, T.J., Weinhold, K.J., Randall, R.R., Bolognesi, D.P. and Haynes, B.F., Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 1932-1936.
3. Goudsmit, J., Debouck, C., Meloen, R.H., Smit, L., Bakker, M., Asher, D.M., Wolff, A.V., Gibbs, C.J., Jr. and Gajdusek, D.C., Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 4478-4482.
4. Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K. and Putney, S.D., Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope, J. Virol., 62 (1988) 2107-2114.
5. LaRosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J.A., Profy, A.T., Lewis, J.A., Langlois, A.J., Dreesman, G.R., Boswell, R.N., Shadduck, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Matthews, T.J., Emini, E.A. and Putney, S.D., Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant, Science, 249 (1990) 932-935 and Errata, Science, 251 (1991) 811.
6. LaRosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J.A., Profy, A.T., Lewis, J.A., Langlois, A.J., Dreesman, G.R., Boswell, R.N., Shadduck, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Matthews, T.J., Emini, E.A. and Putney, S.D., Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant, Science, 249 (1990) 932-935 and Errata, Science, 251 (1991) 811.
7. Javaherian, K., Langlois, A.J., LaRosa, G.J., Profy, A.T., Rusche, J.R., Bolognesi, D.P., Herlihy, W.C., Putney, S.D. and Matthews, T.J., Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1, Science, 250 (1990) 1590-1593.
8. Hattori, T., Koito, A., Takatsuki, K., Kido, H. and Katunuma, N., Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection, FEBS Lett., 248 (1989) 48-52.
9. Stephens, P.E., Clements, G., Yarranton, G.T. and Moore, J., A chink in HIV's armour?, Nature, 343 (1990) 219.
10. Bloom, B.R., A perspective on AIDS vaccines, Science, 272 (1996) 1888-1890.
11. Deng, H.K., Liu, R., Ellmier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P.D., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schall, T.J., Littman, D.R. and Landau, N.R., Identification of a major co-receptor for primary isolates of HIV-1, Nature, 381 (1996) 661-666.
12. + cells is mediated by the chemokine receptor CC-CKR-5, Nature, 381 (1996) 667-673.
13. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. and Berger, E.A., CCCKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofector for macrophage-tropic HIV-1, Science, 272 (1996) 1955-1958.
14. Dyson, H. and Wright, P.E., Defining solution conformations of small linear peptides, Annu. Rev. Biophys. Biophys. Chem., 20 (1991) 519-538.
15. Dyson, H. and Wright, P.E., Antigenic peptides, FASEB J., 9 (1995) 37-42.
16. de Lorimier, R. and Spicer, L.D., Tech. Protein Chem., V (1994) 423-430.
17. Chandrasekhar, K., Profy, A.T. and Dyson, H.J., Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120, Biochemistry, 30 (1991) 9187-9194.
18. IIIB: A two dimensional NMR study, Biochemistry, 31 (1992) 6972-6979.
19. de Lorimier, R., Moody, M.A., Haynes, B.F. and Spicer, L.D., NMR derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus, Biochemistry, 33 (1994) 2055-2061.
20. Vu, H.M., de Lorimier, R., Moody, M.A., Haynes, B.F. and Spicer, L.D., Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF, Biochemistry, 35 (1996) 5158-5165.
21. Markert, R.L.M., Ruppach, H., Gehring, S., Dietrich, U., Mierke, D.F., Kock, M., Rubsamen-Waigmann, H. and Griesinger, C., Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2, Eur. J. Biochem., 237 (1996) 188-204.
22. Gupta, G., Anantharamaiah, G.M., Scott, D.R., Eldrige, J.H. and Myers, G., Solution structure of the V3 loop of a Thailand HIV isolate, J. Biomol. Struct. Dyn., 11 (1993) 345-366.
23. Catasti, P., Fontenot, J.D., Bradbury, E.M. and Gupta, G., Local and global structural properties of the HIV-MN V3 loop, J. Biol. Chem., 270 (1995) 2224-2232.
24. Catasti, P., Bradbury, E.M. and Gupta, G., Structure and polymorphism of HIV-1 third variable loops, J. Biol. Chem., 271 (1996) 8236-8242.
25. Zvi, A., Kustanovich, I., Feigelson, D., Levy, R., Eisenstein, M., Matsushita, S., Richalet-Secordel, P., Regenmortel, M. and Anglister, J., NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody, Eur. J. Biochem., 229 (1995) 178-187.
26. Wilmot, C.M. and Thornton, J.M., Analysis and prediction of the different types of β-turn in proteins, J. Mol. Biol., 203 (1988) 221-232.
27. Ghira, J.B., Stura, E.A., Stanfield, R.L., Profy, A.T. and Wilson, I.A., Crystal structure of the principal neutralization site of HIV-1, Science, 264 (1994) 82-85.
28. Wuthrich, K., NMR of Proteins and Nucleic Acids, Wiley, New York, 1986.
29. Gunasekaran, K., Ramakrishnan, C. and Balaram, P., Stereochemical analysis of the antigenic tip of the V3 loop peptide of HIV-1 gp120, Int. J. Pept. Protein Res., 46 (1995) 359-365.
30. Isogai, Y., Nemethy, G., Rackovsky, S., Leach, S.J. and Scheraga, H.A., Characterization of multiple bends in proteins, Biopolymers, 19 (1980) 1183-1210.
31. States, D.J., Haberkorn, R.A. and Ruben, D.J., A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants, J. Magn. Reson., 48 (1982) 286-292.
32. Rizo, J., Dhingra, M.M. and Gierasch, L.M., In: P. Balaram and S. Ramseshan (Eds.), Molecular Conformation and Biological Interactions, Thompson Press, Faridabad, 1991, pp. 469-496.
33. Dyson, H.J., Rance, M., Houghten, R.A., Lerner, R.A. and Wright, P.E., Folding of immunogenic peptide fragments of proteins in water solution, J. Mol. Biol., 201 (1988) 161-200.
34. Wuthrich, K., Billeter, M. and Braun, W., Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances, J. Mol. Biol., 180 (1984) 715-740.
35. Kessler, H., Conformation and biological activity of cyclic peptides, Angew. Chem. Int. Ed. Engl., 21 (1982) 512-523.
36. Jelicks, L.A., Naider, F.R., Shenbagamurti, P., Becker, J.M. and Broido, M.S., A type II β-turn in a flexible peptide: proton assignment and conformational analysis of the α-factor from Saccharomyces cerevisiae in solution, Biopolymers, 27 (1988) 431-449.